Clinical Study
Polymorphisms of MTHFR Associated with Higher Relapse/Death Ratio and Delayed Weekly MTX Administration in Pediatric Lymphoid Malignancies
Table 1
Patient characteristics.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ALL: acute lymphoblastic leukemia; NHL: non-Hodgkin’s lymphoma; BCP: B-cell precursor leukemia; T: T-cell linage; CR: complete remission. |